Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Demonstrates that synchronous cardiac and CNS diffuse large B-cell lymphoma can be safely diagnosed via TTE- and fluoroscopy-guided endomyocardial biopsy (even in patients declining blood products) and achieve rapid complete remission with timely chemoimmunotherapy.
Primary cardiac lymphoma is a rare diagnosis.1 Patients most commonly present with heart failure symptoms and are at times simultaneously infected with HIV/AIDS.2 Histopathological findings obtained from cardiac biopsy are the reference standard for diagnosis in these patients; however, the benefits of the biopsy approach must be weighed against a patient's individual values as well as the overall risks and yield of the procedure. Given the positive response to treatment, cardiac lymphoma should be considered when patients present with new heart failure symptoms and a right-sided mass on imaging.
No takes yet. Share an insight, caveat, or question.
Bradbury et al. (2024) conducted a case report in Synchronous cardiac and central nervous system diffuse large B-cell lymphoma (DLBCL) (n=1). Transjugular endomyocardial biopsy under fluoroscopy and TTE guidance followed by dose-attenuated anthracycline-containing hyperCVAD chemotherapy (cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, cytarabine, and rituximab) with darbepoetin alfa and eltrombopag support was evaluated on Resolution of cardiac and CNS lymphoma masses and clinical symptoms at 2 months.
Synapse has enriched 10 related papers. Consider them for comparative context: